Clinical Guides
Approach to Diabetes Mellitus
A clinically focused clinical approach to adult diabetes mellitus in India, covering diagnostic confirmation, type and emergency assessment, individualised cardiometabolic treatment, pregnancy, complications, monitoring and access-aware continuity of care.
MedNext Academy | 13 min read
Approach to Diabetes Mellitus
A clinically focused clinical approach to adult diabetes mellitus in India, covering diagnostic confirmation, type and emergency assessment, individualised cardiometabolic treatment, pregnancy, complications, monitoring and access-aware continuity of care.
Summary
Diabetes mellitus is a group of disorders characterised by chronic hyperglycaemia arising from impaired insulin secretion, impaired insulin action or both. The clinical task extends beyond attaching a type 2 label to an elevated glucose. At first contact, decide whether the result is diagnostic and needs confirmation, whether the person might have type 1 or another form, and whether diabetic ketoacidosis, hyperosmolar hyperglycaemic state, severe hypoglycaemia or an acute precipitant requires emergency care. A young or lean adult, rapid weight loss, ketosis, short symptom history or autoimmune disease should lower the threshold for urgent insulin-deficiency assessment.
In a person without unequivocal hyperglycaemia, diagnosis requires confirmation with a repeat abnormal test or a second abnormal diagnostic test. HbA1c is convenient but can mislead when red-cell turnover, haemoglobin variants, anaemia, pregnancy or advanced kidney disease changes its relationship with glucose. Classification remains revisable: type 1 diabetes, type 2 diabetes, gestational diabetes, monogenic diabetes, pancreatic disease and medicine-induced diabetes require different decisions.
Management is comprehensive risk reduction. Nutrition, physical activity, weight, sleep, tobacco exposure, mental health, blood pressure, lipids, kidney function, cardiovascular disease, eye disease, neuropathy, feet and reproductive plans belong in the same plan as glucose. Medicines are chosen through shared decisions that consider cardiorenal benefit, hypoglycaemia, weight, renal function, pregnancy, adverse effects, cost and supply. Monitoring must lead to action. This guide is educational and cannot replace patient-specific prescribing or organizational clinical review.
How Common Is It?
Diabetes is common in India, but prevalence estimates depend on age, sampling, urban-rural distribution, diagnostic test and whether previously undiagnosed disease is included. A national percentage should not be applied to an individual patient or district. The practical implication is that clinicians should expect both known diabetes and unrecognised hyperglycaemia across primary, emergency, surgical, obstetric and inpatient care, while avoiding indiscriminate testing that cannot be followed by confirmation and treatment.
Type 2 diabetes accounts for most adult cases, yet high frequency increases the danger of premature closure. Type 1 diabetes can present at any age. Pancreatic disease, glucocorticoids, endocrine disorders, haemoglobin disorders, pregnancy and monogenic syndromes may change classification. South Asian populations often develop type 2 diabetes at a younger age and lower body-mass index than some European populations, so absence of marked obesity does not exclude insulin resistance. Conversely, obesity does not prove type 2 diabetes.
The burden reflects duration and vascular risk as much as glucose. Retinopathy, chronic kidney disease, neuropathy, foot disease, atherosclerotic cardiovascular disease, heart failure, infection and metabolic liver disease can be present at or soon after diagnosis of type 2 diabetes because hyperglycaemia may have been silent for years. India's NP-NCD framework supports population-based screening from age thirty and linked primary-care management. Screening is only beneficial when an abnormal point-of-care result is confirmed appropriately, communicated, entered into a reliable follow-up pathway and treated without catastrophic out-of-pocket cost.
Risk Factors
Risk for type 2 diabetes rises with age, family history, South Asian ancestry, overweight or central adiposity, physical inactivity, hypertension, dyslipidaemia, polycystic ovary syndrome, prior gestational diabetes, delivery of a large baby, cardiovascular disease, metabolic dysfunction-associated steatotic liver disease and exposure to diabetogenic medicines. Tobacco use, sleep disorders and social conditions that constrain diet or activity complicate cardiometabolic risk. Asian-specific body-mass-index thresholds may prompt earlier testing, but waist distribution, trajectory and metabolic history matter more than a single label.
Type 1 diabetes reflects autoimmune beta-cell destruction in most cases. Personal or family autoimmune disease, weight loss, polyuria, polydipsia, ketosis and rapid progression support suspicion, but antibody-negative disease and slower adult autoimmune diabetes occur. Pancreatitis, pancreatic surgery, cystic fibrosis, haemochromatosis and pancreatic cancer suggest pancreatogenic diabetes. Glucocorticoids, some antipsychotics, immunotherapies and transplant medicines can precipitate hyperglycaemia; timing and glucose pattern should be documented rather than calling every case routine type 2 diabetes.
Risk of complications is modified by duration, glycaemic exposure, blood pressure, albuminuria, kidney function, lipids, smoking, obesity, pregnancy and access to consistent care. Hypoglycaemia risk increases with insulin or insulin secretagogues, kidney or liver impairment, missed meals, alcohol, frailty and impaired awareness. Ketoacidosis risk is higher with absolute insulin deficiency, acute illness or interrupted insulin; SGLT2 inhibitors can produce ketoacidosis with only modest glucose elevation. These risks should guide education and review frequency, not be treated as reasons to deny effective treatment.
Diagnosis
History
Ask about polyuria, nocturia, polydipsia, weight change, fatigue, blurred vision, candidiasis, recurrent infection, vomiting, abdominal pain, altered cognition and symptoms of hypoglycaemia. Establish onset and tempo, pregnancy possibility, family history including early multigenerational diabetes, autoimmune disease, pancreatitis, alcohol, nutrition, weight trajectory, steroid or antipsychotic use and previous gestational diabetes. Review cardiovascular, renal, neurological, eye and foot symptoms, food security, treatment cost and the person's understanding. Acute breathlessness or deep breathing may be metabolic rather than pulmonary.
Examination
Record hydration, mental state, respiratory pattern, pulse, blood pressure including postural measurement when indicated, weight, body-mass index and waist context. Look for acanthosis, autoimmune or endocrine clues, infection and injection-site problems. Cardiovascular and peripheral vascular examination, foot inspection, pulses, protective sensation and footwear are essential. Assess oedema and signs of kidney, heart or liver disease. A normal examination does not exclude severe hyperglycaemia or early complications.
Investigations
Diagnostic thresholds include HbA1c at least 6.5%, fasting plasma glucose at least 126 mg/dL, two-hour plasma glucose at least 200 mg/dL during a 75-g oral glucose-tolerance test, or random plasma glucose at least 200 mg/dL with classic symptoms or hyperglycaemic crisis. Without unequivocal hyperglycaemia, confirm promptly. If acutely ill, check bedside glucose, blood ketones, venous gas, electrolytes, renal function and osmolality as indicated. Baseline evaluation includes HbA1c, creatinine and eGFR, urine albumin-creatinine ratio, lipids, liver context and complication screening. Use C-peptide, islet antibodies or genetic assessment selectively when classification will change care.
Differential Diagnosis
First distinguish transient or misleading results from persistent diabetes. Stress hyperglycaemia occurs during infection, infarction, surgery or corticosteroid treatment and predicts future risk, but it may not establish chronic diabetes without follow-up. HbA1c can be falsely low or high with altered erythrocyte survival, recent transfusion, iron deficiency, haemoglobin variants, pregnancy or advanced kidney disease. Capillary meter readings are invaluable for immediate safety but a screening strip is not equivalent to a quality-assured laboratory diagnosis. Renal glycosuria and SGLT2 treatment can produce urine glucose without diagnostic plasma hyperglycaemia.
If diabetes is confirmed, classify provisionally and revisit. Type 1 diabetes is suggested by ketosis, rapid catabolism, low endogenous insulin and autoimmunity. Type 2 diabetes is usually gradual and associated with insulin resistance, but phenotypes overlap. Latent autoimmune diabetes in adults can resemble type 2 initially. Monogenic diabetes is considered with young onset, a strong autosomal-dominant family pattern, stable mild fasting hyperglycaemia or syndromic clues. Pancreatogenic diabetes follows exocrine pancreatic disease and may combine insulin deficiency, malabsorption and unstable glucose.
Other secondary causes include Cushing syndrome, acromegaly, hyperthyroidism, haemochromatosis and medicines. In pregnancy, distinguish pre-existing diabetes, overt diabetes first detected in pregnancy and gestational diabetes using an obstetric protocol; routine adult HbA1c targets and oral medicine assumptions do not transfer safely. Polyuria also occurs with diuretics, hypercalcaemia, kidney concentrating defects and diabetes insipidus. Weight loss, abdominal pain or an abrupt glycaemic deterioration can be a warning for pancreatic disease rather than simple lifestyle progression.
Management
Begin with immediate safety and an agreed problem list. Suspected DKA or HHS needs emergency protocol-based fluids, electrolytes, insulin and precipitant treatment with frequent monitoring; it is not managed by simply adding an outpatient tablet. Marked symptomatic hyperglycaemia, catabolism or likely type 1 diabetes often requires urgent insulin and specialist input. For stable type 2 diabetes, agree realistic goals covering symptoms, glucose, cardiovascular and kidney protection, weight or nutrition, blood pressure, lipids, tobacco and complications.
Lifestyle care should be specific, culturally acceptable and sustainable: emphasise minimally processed foods, adequate protein and fibre, portion and carbohydrate quality, replacement of sugary drinks, regular activity including resistance work when safe, sleep and smoking cessation. Avoid blame and extreme diets that interact with insulin or SGLT2 inhibitors. Structured education should include monitoring purpose, hypoglycaemia, sick-day actions, foot care, dental and eye care, and what to do when medicines or food are unaffordable.
Medicine selection is individualised. Metformin remains useful for many people if tolerated and renal function permits. SGLT2 inhibitors and GLP-1 receptor agonists may provide cardiovascular, heart-failure, kidney or weight benefit in appropriate patients; insulin, DPP-4 inhibitors, sulfonylureas and pioglitazone retain roles with different risks. Treatment should follow the current Indian formulary and patient phenotype rather than copy a foreign sequence. Assess established cardiovascular disease, heart failure and CKD early because organ protection may be indicated beyond HbA1c lowering. Reassess efficacy, adverse effects, adherence, access and therapeutic inertia at every follow-up.
Prescribing Information
Before prescribing, verify diabetes type, current glucose severity, renal and hepatic function, pregnancy or conception plans, comorbidity, hypoglycaemia risk, interactions, affordability and reliable supply. Metformin commonly causes gastrointestinal effects; titration with food and an appropriate formulation can improve tolerance. Avoid it in severe renal impairment and hold or review it during acute hypoxia, shock or major kidney deterioration according to local policy. Long-term use can contribute to vitamin B12 deficiency, especially when neuropathy or anaemia appears.
SGLT2 inhibitors can cause genital mycotic infection, volume depletion and ketoacidosis, sometimes with glucose below classic DKA levels. Teach pause rules for significant fasting, severe acute illness and selected procedures, and seek urgent ketone assessment for nausea, abdominal pain or deep breathing. GLP-1 receptor agonists commonly cause gastrointestinal symptoms and require product-specific contraindication and pregnancy review. Sulfonylureas and insulin can cause hypoglycaemia and weight gain; renal impairment, missed meals and driving increase consequence. Pioglitazone can cause oedema and is unsuitable in heart failure; DPP-4 inhibitors need product-specific renal review.
Insulin education must cover device and concentration, injection technique, site rotation, storage, meal relation, glucose checks, dose adjustment plan, hypoglycaemia treatment and access during travel or illness. Never omit basal insulin in type 1 diabetes because the person is not eating. Pregnancy requires specialist review: some routinely used glucose, blood-pressure and lipid medicines are unsuitable before conception or during pregnancy. Brand substitution, fixed combinations and shortages can create dosing errors. Every prescription needs a documented target, review date, monitoring plan and clear ownership; this guide does not supply patient-specific doses.
When to Refer
Arrange emergency care for suspected DKA or HHS, severe dehydration, persistent vomiting, deep or laboured breathing, significant ketonaemia, altered mental state, shock, severe hypoglycaemia not responding to oral treatment, or sepsis and vascular events with metabolic instability. New probable type 1 diabetes, especially in a child, adolescent, pregnant person or catabolic adult, requires same-day specialist-supported assessment and must not wait for routine HbA1c confirmation.
Refer promptly when classification is uncertain and the answer changes treatment: recurrent ketosis, rapid failure of non-insulin therapy, low body weight with catabolism, suspected monogenic disease, pancreatic disease, severe insulin resistance or immune-checkpoint-inhibitor exposure are examples. Pregnancy planning, pregnancy with diabetes and gestational diabetes need a multidisciplinary obstetric-diabetes pathway. Advanced CKD, rapidly falling eGFR, substantial albuminuria, resistant hypertension, recurrent severe hypoglycaemia, impaired awareness or complex insulin technology also justify specialist involvement.
Complication referral should be organ-specific and timely. Urgent eye review is needed for sudden visual change; routine retinal screening must not wait for symptoms. An active foot ulcer, infection, ischaemia, gangrene or suspected Charcot arthropathy needs rapid multidisciplinary assessment. Refer for suspected acute coronary syndrome, stroke or decompensated heart failure by emergency pathways. Persistent distress, eating disorder, severe depression or inability to self-manage safely warrants mental-health and social support. Referral should not end primary-care ownership: share the current medicines, results, question, urgency and follow-up responsibility, and confirm that cost and travel do not make the plan fictional.
Red Flags
Metabolic red flags include vomiting, abdominal pain, dehydration, fruity breath, Kussmaul respiration, drowsiness, confusion, hypotension, severe weakness and positive blood ketones. DKA can occur with a glucose lower than expected, particularly in pregnancy or with SGLT2 inhibitors. HHS often presents with profound dehydration, very high glucose and altered cognition in an older person, but mixed DKA-HHS occurs. Do not delay emergency treatment to determine the perfect diabetes subtype.
Severe hypoglycaemia is defined clinically by the need for assistance, not by a single number. Seizure, unconsciousness or inability to swallow requires emergency treatment and investigation of insulin, secretagogue, kidney function, food intake and alcohol. Recurrent nocturnal symptoms, impaired awareness or episodes while driving require urgent regimen review. Infection can be subtle in diabetes; fever, hypotension, rapidly spreading skin change, a hot swollen foot or systemic deterioration demands prompt assessment.
Vascular and organ red flags include acute chest pain, focal neurological deficit, sudden breathlessness, abrupt visual loss, oliguria and pulmonary oedema. A foot that is ulcerated, black, cold, pulseless, malodorous, crepitant or acutely warm and deformed is not a routine annual-review problem. Pregnancy with hyperglycaemia, ketones, reduced fetal movement or hypertension needs urgent obstetric-diabetes contact. Rapid unintended weight loss, pain radiating to the back or a sudden worsening of previously stable diabetes can signal pancreatic pathology. Missed insulin because of cost, supply failure or inability to inject is also a safety emergency that requires a practical bridge rather than admonishment.
Indian Clinical Context
India's NP-NCD programme supports population-based screening from age thirty, confirmation, primary-care management, referral and longitudinal recording. A community or health-and-wellness-centre glucose strip can identify a suspected case, but the programme guidance itself distinguishes screening from confirmation. Diagnosis should use a quality-assured plasma test or validated HbA1c approach, and the patient needs a reachable follow-up route. Screening without communication, confirmatory testing or medicine availability creates a label rather than care.
The ICMR type 2 diabetes guideline provides an Indian framework for lifestyle, glucose-lowering therapy and annual assessment of eyes, kidney and feet, but its 2018 medicine sequence must be interpreted alongside newer cardiorenal outcome evidence and current formularies. current guidelines (2026) and ADA 2026 illustrate the move from glucose-only escalation toward organ protection; their exact product availability, licensing and cost cannot be imported as an Indian national protocol. Generic medicines, state procurement, insurance, private purchase and cold-chain reliability vary. Prescribe a plan the person can continue, and document a safe alternative if supply fails.
Food advice should work with regional diets, work patterns, fasting practices and household budgets rather than ban a staple food without replacement. Insulin storage requires practical discussion during heat, travel and power interruption. HbA1c, urine albumin-creatinine ratio, retinal photography, podiatry and newer medicines may be unavailable or unaffordable in some districts; this should trigger prioritised referral and high-value monitoring, not invented results. Community health workers can strengthen recall and adherence when consent and privacy are protected. Avoid stigma: diabetes is a biological disease shaped by genetics, environment and access, not a moral failure.
NMC Competency Mapping
The NMC Medicine diabetes cluster maps the clinical presentation, diagnosis, investigations, complications, emergencies and pharmacotherapy of diabetes. IM11.7 addresses chronic complications, IM11.9 clinical presentation, IM11.11 glucose, electrolytes, blood gas, ketones and renal investigations, IM11.13 urinary ketone testing, IM11.15 diabetic emergencies and principles of therapy, and IM11.16 diabetes medicines. These outcomes integrate with physiology of insulin and counter-regulation, biochemistry of carbohydrate and lipid metabolism, pathology of microvascular disease, pharmacology, ophthalmology, surgery, obstetrics, paediatrics and community medicine.
A graduating learner should confirm diagnostic criteria, identify when HbA1c is unreliable, avoid assuming type 2 diabetes, assess DKA and HHS, and present a complete baseline complication and cardiovascular-risk screen. Supervised skills include capillary glucose and ketone testing, blood-pressure technique, injection and meter teaching, foot inspection, pulse and monofilament assessment, and structured sick-day counselling. The learner should interpret eGFR, albuminuria, lipids and retinal-screening reports and know when urgent referral overrides routine follow-up.
Assessment should reward prioritisation. A useful OSCE gives a symptomatic adult with glucose and ketone results and asks for immediate safety actions, provisional classification, confirmatory plan and communication. Another can test shared medicine choice in CKD with explicit cost constraints and pregnancy potential. Exact competency wording and performance levels must be confirmed against the institution's authorised 2024 curriculum ledger. This mapping does not certify independent insulin titration, emergency management, pregnancy care or completion of MedNext Clinical Team review.
Key Exam Pearls for NEET PG
Diagnostic thresholds are HbA1c at least 6.5%, fasting plasma glucose at least 126 mg/dL, two-hour glucose at least 200 mg/dL after a 75-g OGTT, or random glucose at least 200 mg/dL with classic symptoms or crisis. In asymptomatic people without unequivocal hyperglycaemia, confirm the diagnosis. HbA1c reflects glycation rather than direct current glucose and is unreliable when red-cell turnover or haemoglobin biology is abnormal. Glycosuria does not equal diabetes, particularly with SGLT2 therapy.
Type 1 diabetes can present in adults, and obesity does not exclude it. DKA combines ketonaemia and metabolic acidosis; glucose may be modest in euglycaemic DKA. HHS features marked hyperosmolality and dehydration with little or no major ketoacidosis, but overlap is common. Total-body potassium is depleted in DKA even when the initial serum potassium is normal or high. Never stop basal insulin in type 1 diabetes simply because oral intake has stopped.
Microvascular complications are retinopathy, nephropathy and neuropathy. Albuminuria and eGFR provide complementary kidney information. A warm swollen relatively painless foot suggests Charcot neuroarthropathy; an infected or ischaemic diabetic foot is urgent. Cardiovascular and kidney benefits can drive SGLT2-inhibitor or GLP-1-receptor-agonist selection beyond HbA1c, while insulin and sulfonylureas carry hypoglycaemia risk. Metformin can contribute to vitamin B12 deficiency. Pregnancy changes targets and medicine safety, so preconception review is high yield. The best management answer individualises glycaemia, organ protection, weight, hypoglycaemia, renal function, pregnancy, cost and patient preference rather than chasing one HbA1c number.
Frequently Asked Questions
Does one abnormal HbA1c or fasting glucose result always establish diabetes mellitus?
Not always. If there are no classic symptoms or unequivocal hyperglycaemia, the abnormal result should be confirmed promptly with a repeat or a second diagnostic test. HbA1c may be misleading with anaemia, altered red-cell turnover, haemoglobin variants, pregnancy, transfusion or advanced kidney disease, so plasma glucose testing may be more appropriate.
Can an adult with overweight or obesity still have type 1 diabetes?
Yes. Body size does not determine diabetes type. Rapid symptoms, weight loss, ketosis, autoimmune disease or early failure of non-insulin treatment should prompt urgent reassessment for insulin deficiency. Adults may have autoimmune diabetes with slower progression, and delayed recognition can lead to ketoacidosis. Classification should remain revisable as evidence accumulates.
Why are heart and kidney conditions considered when selecting a glucose-lowering medicine?
Some SGLT2 inhibitors and GLP-1 receptor agonists have demonstrated cardiovascular or kidney benefits in selected populations, so treatment is no longer based only on the HbA1c reduction. Choice still depends on diabetes type, eGFR, heart failure, adverse effects, pregnancy, hypoglycaemia, weight goals, licensing, cost and reliable local supply.
Which symptoms should make a person with diabetes seek emergency assessment for ketones or metabolic crisis?
Persistent vomiting, abdominal pain, deep or rapid breathing, marked thirst, dehydration, drowsiness, confusion, severe weakness or positive blood ketones require urgent assessment. DKA can occur with only moderate glucose, particularly during pregnancy or SGLT2-inhibitor use. Severe hypoglycaemia, unconsciousness or inability to swallow is also an emergency.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic